Interestingly, of the six prostate cancer patients carrying disease-associated BRCA2 mutations, 50% were diagnosed before age 50 and most had no family history of prostate cancer (five out of six) or breast cancer (four out of six) (Edwards et al, 2003). This evidence concerns the gene BRCA2 and prostate carcinoma.